A rapid and simple detection method for the BRAFT1796A mutation in fine-needle aspirated thyroid carcinoma cells

Thyroid

Volumn 14, Issue 11, 2004, Pages 910-915

  Hayashida, Naomi ^a   Namba, Hiroyuki ^a   Kumagai, Atsushi ^a   Hayashi, Tomayoshi ^b   Ohtsuru, Akira ^b   Ito, Masahiro ^c   Saenko, Vladimir A ^a   Maeda, Shigeto ^a   Kanematsu, Takashi ^a   Yamashita, Shunichi ^a,b  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; ISOPROTEIN; PROTEIN SERINE THREONINE KINASE; RAF PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; ASPIRATION BIOPSY; CANCER CYTODIAGNOSIS; CANCER SIZE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; FOLLICULAR CARCINOMA; HODGKIN DISEASE; HUMAN; HUMAN CELL; MEDULLARY CARCINOMA; MISMATCH REPAIR; NODULAR GOITER; PAPILLARY CARCINOMA; POLYMERASE CHAIN REACTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SOMATIC MUTATION; THYROID CARCINOMA; UNDIFFERENTIATED CARCINOMA;

EID: 10044286181     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2004.14.910     Document Type: Article

References (23)

1. Peyssonnaux C, Eychene A 2001 The Raf/MEK/ERK pathway: New concepts of activation. Biol Cell 93:53-62.
2. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA 2002 Mutations of the BRAF gene in human cancer. Nature 417:949-954.
3. Cohen Y, Xing M, Mambo E, Guo Z, Wu G, Trink B, Beller U, Westra WH, Ladenson PW, Sidransky D 2003 BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 95:625-627.
4. Fukushima T, Suzuki S, Mashiko M, Ohtake T, Endo Y, Takehayashi Y, Sekikawa K, Hagiwara K, Takenoshita S 2003 BRAF mutations in papillary carcinomas of the thyroid. Oncogene 22:6455-6457.
5. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA 2003 High prevalence of BRAF mutations in thyroid cancer: Genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 63:1454-1457.
6. Namba H, Nakashima M, Hayashi T, Hayashida N, Maeda S, Rogounovitch TI, Ohtsuru A, Saenko VA, Kanematsu T, Yamashita S 2003 Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers. J Clin Endocrinol Metab 88:4393-4397.
7. Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, Zhu Z, Giannini R, Salvatore G, Fusco A, Santoro M, Fagin JA, Nikiforov YE 2003 BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 88:5399-5404.
8. Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, Maximo V, Botelho T, Seruca R, Sobrinho-Simoes M 2003 BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 22:4578-4580.
9. Xu X, Quiros RM, Gattuso P, Ain KB, Prinz RA 2003 High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines. Cancer Res 63:4561-4567.
10. Hedinger C, Williams ED, Sobin LH 1989 The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63:908-911.
11. Kitahori Y, Naito H, Konishi N, Ohnishi T, Shirai T, Hiasa Y 1995 Frequent mutations of Ki-ras codon 12 in N-bis (2-hydroxypropyl)-nitrosamine- initiated thyroid, kidney and lung tumors in Wistar rats. Cancer Lett 96:155-161.
12. Mitsudomi T, Viallet J, Mulshine JL, Linnoila RI, Minna JD, Gazdar AF 1991 Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. Oncogene 6:1353-1362.
13. Ball ED, Mills LE, Neubauer A, Liu E 1990 Detection of minimal acute myeloid leukemia cells in bone marrow by probing for mutated ras oncogenes using the polymerase chain reaction. Prog Clin Biol Res 333:499-506.
14. Cogswell PC, Morgan R, Dunn M, Neubauer A, Nelson P, Poland-Johnston NK, Sandberg AA, Liu E 1989 Mutations of the ras protooncogenes in chronic myelogenous leukemia: A high frequency of ras mutations in bcr/abl rearrangement-negative chronic myelogenous leukemia. Blood 74:2629-2633.
15. Mane SM, Meltzer SJ, Gutheil JC, Kapil V, Lee EJ, Needleman SW 1990 RAS gene activation in acute myelogenous leukemia: Analysis by in vitro amplification and DNA base sequence determination. Genes Chromosomes Cancer 2:71-77.
16. Dina R, Capitanio A, Damiani S 2000 A morphometric analysis of cytological features of tall cell variant and classical papillary carcinoma of the thyroid. Cytopathology 11:124-128.
17. Nair M, Kapila K, Karak AK, Verma K 2001 Papillary carcinoma of the thyroid and its variants: A cytohistological correlation. Diagn Cytopathol 24:167-173.
18. Alexander EK, Heering JP, Benson CB, Frates MC, Doubilet PM, Cibas ES, Marqusee E 2002 Assessment of nondiagnostic ultrasound-guided fine needle aspirations of thyroid nodules. J Clin Endocrinol Metab 87:4924-4927.
19. Belfiore A, La Rosa GL 2001 Fine-needle aspiration biopsy of the thyroid. Endocrinol Metab Clin North Am 30:361-400.
20. Mao L, Hruban RH, Boyle JO, Tockman M, Sidransky D 1994 Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res 54:1634-1637.
21. Sidransky D, Von Eschenbach A, Tsai YC, Jones P, Summerhayes I, Marshall F, Paul M, Green P, Hamilton SR, Frost P, et al 1991 Identification of p53 gene mutations in bladder cancers and urine samples. Science 252:706-709.
22. Kondo H, Sugano K, Fukayama N, Kyogoku A, Nose H, Shimada K, Ohkura H, Ohtsu A, Yoshida S, Shimosato Y 1994 Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma. Cancer 73:1589-1594.
23. Sidransky D, Tokino T, Hamilton SR, Kinzler KW, Levin B, Frost P, Vogelstein B 1992 Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 256:102-105.